Video

Understanding Supportive Services in Lung Cancer

As a part of its Speaking Out Video series, CURE® spoke with Terri Conneran, on behalf of KRAS Kickers, about supportive services for lung cancer.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of Dr. Reznick
There are a number of reasons why patients with cancer are encouraged to enroll in clinical trials, Dr. Michael J. Pishvaian explained.
a man and a woman in front of a dark blue background for CURE Speaking Out
a man and a woman in front of a dark blue background for CURE Speaking Out
a man and a woman in front of a dark blue background for CURE Speaking Out
a man and a woman in front of a dark blue background for CURE Speaking Out
a man and a woman in front of a dark blue background
a man and a woman in front of a dark blue background
a man and a woman in separate boxes in front of a dark blue background
Related Content
Among patients with advanced squamous NSCLC, ivonescimab plus chemo was associated with positive progression-free survival results: © Steph_photagraphies - stock.adobe.com.
April 23rd 2025

Ivonescimab Plus Chemo May Slow Advanced NSCLC Progression

Alex Biese
In patients with advanced squamous non–small cell lung cancer, ivonescimab plus chemo was associated with progression-free survival results.
CURE Cancer Horizons logo
February 26th 2024

FDA Approvals from February 2024

Alex Biese Brielle Benyon
February brought in multiple FDA approvals in the oncology space. Here’s an overview of some of the most recent ones.
LCI, in cooperation with a statewide consortium of leaders and healthcare organizations, today announced the launch of Screening Saves.
April 22nd 2025

LCI Launches Screening Saves Program

Lung Cancer Initiative (LCI)
Guidelines for Childhood Neuroblastoma, FDA Decisions and More
February 12th 2024

Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Alex Biese Brielle Benyon
Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews
Deferring upfront CNS-directed radiation in EGFR-variant and ALK-positive NSCLC may improve outcomes but raises treatment-related toxicity risks: © stock.adobe.com
April 18th 2025

Radiation Delay in NSCLC May Aid Outcomes, But Raises Toxicity Risks

Alex Biese
Deferring upfront CNS-directed radiation in EGFR-variant and ALK-positive NSCLC may improve outcomes but raises treatment-related toxicity risks.
15% of U.S. Cancer Patients Are Active Smokers at Time of Diagnosis: © stock.adobe.com
April 16th 2025

15% of U.S. Cancer Patients Are Active Smokers at Time of Diagnosis

Yale School of Medicine
The addition of smoking status to the National Cancer Database might inform more effective treatment for smokers with cancer.